{"id":"W2167188058","doi":"10.1056/nejmoa1109653","title":"Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer","year":2011,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2828,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Everolimus; Medicine; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Endocrine system; Breast cancer; Hormone receptor; Sirolimus; Hormone; Internal medicine; Cancer research; Cancer; Oncology; Endocrinology; Signal transduction; Biology; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null}